Femura Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
- Paid Up Capital ₹ 2.00 M
- Company Age 10 Year, 4 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 1.00 Cr
- Revenue Growth -11.26%
- Profit Growth -5.18%
- Ebitda -83.39%
- Net Worth 4.87%
- Total Assets -22.45%
About Femura Pharmaceuticals
Femura Pharmaceuticals Private Limited (FPPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 September 2014 and has a history of Ten years and four months. Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 2.00 M.
The company currently has active open charges totaling ₹1.00 Cr.
Subramaniam Arathi, Arasikere Panchaksharaiah, Rameshbabu Dwaraknath, and Seven other members serve as directors at the Company.
Company Details
-
Location
Bangaluru, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24230KA2014PTC076514
-
Company No.
076514
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
19 Sep 2014
-
Date of AGM
30 Sep 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Femura Pharmaceuticals?
Board Members (10)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Subramaniam Arathi
|
Director | 19-Sep-2014 | Current |
|
Arasikere Panchaksharaiah
|
Additional Director | 26-Mar-2015 | Current |
|
Rameshbabu Dwaraknath
|
Additional Director | 26-Mar-2015 | Current |
|
Mayur Mehta
|
Additional Director | 26-Mar-2015 | Current |
|
Chandrashekar Kumar
|
Director | 01-Sep-2020 | Current |
|
Rudregowda Praveen
|
Additional Director | 26-Mar-2015 | Current |
Financial Performance of Femura Pharmaceuticals.
Femura Pharmaceuticals Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 11.26% decrease. The company also saw a slight decrease in profitability, with a 5.18% decrease in profit. The company's net worth moved up by a moderate rise of 4.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Femura Pharmaceuticals?
In 2019, Femura Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹10.00 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 1.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Feb 2018 | State Bank Of India | ₹1.00 Cr | Open |
How Many Employees Work at Femura Pharmaceuticals?
Femura Pharmaceuticals has a workforce of 26 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Femura Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Femura Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.